Monica Lupi

10PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 10, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).

Kerem Wainer-Katsir, Adi Haber, Hila Fishman

|Jul 15, 2022
Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations.

Laura Mannarino, Federica Mirimao, Nicolò Panini

|May 28, 2022
Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study.

Laura Mannarino, Lara Paracchini, Federica Pezzuto

|Apr 12, 2022
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells.

Michela Chiappa, Federica Guffanti, Martina Anselmi

|Feb 08, 2022
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.

Carmen Ghilardi, Catarina Moreira-Barbosa, Laura Brunelli

|Jan 11, 2022
Role of cardiolipins, mitochondria, and autophagy in the differentiation process activated by all-trans retinoic acid in acute promyelocytic leukemia.

Maurizio Gianni', Laura Goracci, Anna Schlaefli

Pageof 2

Frequent Collaborators

2 joint publications

Luca Guarrera

2 joint publications

Maurizio D'Incalci

2 joint publications

Enrico Garattini

1 joint publications

Umberto Capasso Palmiero